/Companies

Nectome

YC W18

San Francisco, US · 9 employees · 12 known investors

Find your way into Nectome

Sign up to see every warm intro you have to Nectome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nectome team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

BiotechDeep TechHealthtechLongevityNeurotechnologyHealthcareUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W18)

ASAurelia Song
Aurelia SongCEOAurelia Song is the founder and CEO of Nectome, a company developing preservation technology aimed at enabling future revival of terminally ill individuals.
MR
Michael Ruzo (McCanna)

Investors · 12

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us

BEENEXTreportedSingapore

How we know: Y Combinator's founder network · Not right? Tell us

ChainFund CapitalreportedSilicon Valley

How we know: Y Combinator's founder network · Not right? Tell us

Full Tilt CapitalreportedRaleigh

How we know: Y Combinator's founder network · Not right? Tell us

Joey Krugreported

How we know: Y Combinator's founder network · Not right? Tell us

Republic VenturesreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Thiel CapitalreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

V1 VCreportedBoulder · $100K – $300K

How we know: Y Combinator's founder network · Not right? Tell us

Venture Investment AssociatesreportedPeapack

How we know: Y Combinator's founder network · Not right? Tell us

Zarco Investment Groupreported

How we know: Y Combinator's founder network · Not right? Tell us

Company profile

researched Aug 2026

Nectome is a San Francisco-based company offering whole-body human preservation performed post-mortem, with the stated goal of enabling possible revival in the future. The company says it aims to preserve people within minutes after legal death so that both the body and the brain are maintained at a very high level of structural quality.

According to the company, that level of detail is intended to allow the connections between neurons and synapses to be traced throughout the brain. Nectome cites modern neuroscience for the proposition that a person's memory, skills and personality reside in this structure, and states its belief that the scientific and clinical literature supports the view that its preservation protocol can preserve an individual for hundreds of years in sufficient detail that revival is a theoretical possibility over the long term. The company draws an analogy to DNA preservation, which was feasible before genomes could be sequenced, arguing that verifiable preservation can precede the ability to interpret the underlying biology.

Business model

Nectome provides a preservation service performed after legal death, contracted directly with individuals; the website directs prospective customers to contact the company by email.

▸Full profile — technology, go-to-market, geography

Technology

A preservation protocol applied within minutes of legal death that is intended to preserve the body and brain at a level of detail sufficient to trace neuronal and synaptic connections and to maintain the tissue for hundreds of years.

Go-to-market

Direct inquiry through the company website, which invites prospective clients to email the company.

Individuals at the end of their lives, for whom the company positions preservation as a remaining experimental option that may permit recovery in the future.

Geography

Headquartered in San Francisco, United States.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Related companies · 6

Mindstate Design LabsMindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
CircumventCircumvent develops precision medicines for neurodegenerative diseases, with current focus on Batten Disease and other rare neurological disorders. The company's research targets synaptic dysfunction and lysosomal pathways through investigation of the palmitoylome.
Torpedo TherapeuticsTorpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Exin TherapeuticsExin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.
AuricleAuricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.
Read on Scientific AmericanScientific American is a media organization that publishes research and ideas across science, health, technology and society through multiple formats including print, web, video, and podcasts. Founded in 1845, it reaches over 20 million people monthly and maintains editorial independence while providing trustworthy science communication and commentary.

Companies working in the same space as Nectome.

Legal entities · 1

corporate structure
Nectome Inc.

In the news

▸Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Nectome do?
Nectome offers whole-body and brain preservation within minutes of legal death, aiming at possible future revival.
Who founded Nectome?
Nectome was founded by Aurelia Song.
Who are Nectome's investors?
Nectome's investors include Great Oaks Venture Capital, Utopian Ventures, Y Combinator, BEENEXT, ChainFund Capital, Full Tilt Capital, Joey Krug, Republic Ventures and 4 more.
Where is Nectome headquartered?
Nectome is headquartered in San Francisco, US.